Assignee
4TEEN4 Pharmaceuticals GmbH
DE·2 granted patents·8 pending applications·3 citations·filing 2018–2025
Top patents by PatentIndex Score
10 records- 0193US11726094B2Methods for determining DPP3 and therapeutic methods4TEEN4 Pharmaceuticals GmbH·Filed 2020·Granted Aug 15, 2023·3 cites·4 claims
- 0279US2024385197A1Methods for determining dpp3 and therapeutic methods4TEEN4 Pharmaceuticals GmbH·Filed 2023·Application pending·0 cites
- 0366US2023295344A1Dpp3 binder directed to and binding to specific dpp3-epitopes and its use in the prevention or treatment of diseases/acute conditions that are associated with oxidative stress4TEEN4 Pharmaceuticals GmbH·Filed 2022·Application pending·0 cites
- 0462US2026028423A1Prediction of an increase of dpp3 in a patient with septic shock4TEEN4 Pharmaceuticals GmbH·Filed 2023·Application pending·0 cites
- 0561US11530276B2DPP3 binder directed to and binding to specific DPP3-epitopes and its use in the prevention or treatment of diseases / acute conditions that are associated with oxidative stress4TEEN4 Pharmaceuticals GmbH·Filed 2018·Granted Dec 20, 2022·0 cites·6 claims
- 0659US2026083672A1Formulations and dosage amounts for administering an anti-dpp3 antibody or fragment thereof to humans4TEEN4 Pharmaceuticals GmbH·Filed 2025·Application pending·0 cites
- 0754US2023193348A1Dpp3 for therapy guidance, monitoring and stratification of nt-adm antibodies in patients with shock4TEEN4 Pharmaceuticals GmbH·Filed 2021·Application pending·0 cites
- 0853US2023213519A1Dpp3 in patients infected with coronavirus4TEEN4 Pharmaceuticals GmbH·Filed 2021·Application pending·0 cites
- 0951US2022307065A1Therapy guidance and/or therapy monitoring for treatment of shock4TEEN4 Pharmaceuticals GmbH·Filed 2020·Application pending·0 cites
- 1050US2022211798A1Therapy guidance and/or therapy monitoring for a treatment with angiotensin-receptor-agonist and/or a precursor thereof4TEEN4 Pharmaceuticals GmbH·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when 4TEEN4 Pharmaceuticals GmbH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →